Identifying chemotherapy beneficiaries in nasal and paranasal sinus cancers: epidemiological trends and machine learning insights
This study revealed a declining trend in incidence rates beginning in 2012. The gradient boosting model demonstrated robust performance, playing a crucial role in predicting patient prognosis and the significance of chemotherapy.
Authors
- Xinyi Hong (ORCID: https://orcid.org/0000-0001-5563-6055)
- Sufang Qiu (ORCID: https://orcid.org/0000-0001-7660-6955)
- Xin Chen (ORCID: https://orcid.org/0009-0004-0966-6025)
- Zihan Chen (ORCID: https://orcid.org/0009-0006-3412-0897)
- Jing Wang (ORCID: https://orcid.org/0000-0003-4896-0142)
- Wenxi Wu
- Yuhui Pan
- Zijie Wu (ORCID: https://orcid.org/0000-0002-7378-3726)
- Zongwei Huang (ORCID: https://orcid.org/0000-0003-0981-2999)
- Youliang Weng
Institutions
- Fujian Medical University (CN)
- Fudan University Shanghai Cancer Center (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1186/s40001-025-02425-6
- Primary Topic
- Head and Neck Surgical Oncology
- Type
- article
- Field-Weighted Citation Impact
- 0.00